Related references
Note: Only part of the references are listed.Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis
Thomas Karagiannis et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Associations Between General and Abdominal Adiposity and Mortality in Individuals With Diabetes Mellitus
Diewertje Sluik et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2011)
Incretin-Based Therapies for Type 2 Diabetes Mellitus: Properties, Functions, and Clinical Implications
Michael A. Nauck
AMERICAN JOURNAL OF MEDICINE (2011)
Effect of Antihyperglycemic Agents Added to Metformin and a Sulfonylurea on Glycemic Control and Weight Gain in Type 2 Diabetes: A Network Meta-analysis
Jorge L. Gross et al.
ANNALS OF INTERNAL MEDICINE (2011)
Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials
Faramarz Ismail-Beigi et al.
ANNALS OF INTERNAL MEDICINE (2011)
Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations
Wendy L. Bennett et al.
ANNALS OF INTERNAL MEDICINE (2011)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
Ralph A. DeFronzo
DIABETES CARE (2011)
Glycemic Control, Complications, and Death in Older Diabetic Patients The Diabetes and Aging Study
Elbert S. Huang et al.
DIABETES CARE (2011)
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study
James D. Lewis et al.
DIABETES CARE (2011)
Effectiveness of Lifestyle Interventions for Individuals With Severe Obesity and Type 2 Diabetes
Jessica L. Unick et al.
DIABETES CARE (2011)
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
Kasia J. Lipska et al.
DIABETES CARE (2011)
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. F. Deacon
DIABETES OBESITY & METABOLISM (2011)
Triple oral fixed-dose diabetes polypill versus insulin plus metformin efficacy demonstration study in the treatment of advanced type 2 diabetes (TrIED study-II)
D. S. H. Bell et al.
DIABETES OBESITY & METABOLISM (2011)
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials
C. Lamanna et al.
DIABETES OBESITY & METABOLISM (2011)
Effects of initiation and titration of a single pre-prandial dose of insulin glulisine while continuing titrated insulin glargine in type 2 diabetes: a 6-month 'proof-of-concept' study
D. R. Owens et al.
DIABETES OBESITY & METABOLISM (2011)
A STEPWISE APPROACH TO INSULIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND BASAL INSULIN TREATMENT FAILURE
Mayer B. Davidson et al.
ENDOCRINE PRACTICE (2011)
Goals of Glycemic Control in Frail Older Patients With Diabetes
Sei J. Lee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Individuals with diabetes preferred that future trials use patient-important outcomes and provide pragmatic inferences
Mohammad H. Murad et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Intensified glucose control in type 2 diabetes-whose agenda?
John S. Yudkin et al.
LANCET (2011)
TYPE 2 DIABETES MELLITUS IN 2010 Individualizing treatment targets in diabetes care
John B. Buse
NATURE REVIEWS ENDOCRINOLOGY (2011)
Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?
Helen J. Nye et al.
NEPHRON CLINICAL PRACTICE (2011)
Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes
Ebenezer A. Nyenwe et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies
Yoon Kong Loke et al.
BRITISH MEDICAL JOURNAL (2011)
Current Antihyperglycemic Treatment Guidelines and Algorithms for Patients with Type 2 Diabetes Mellitus
Lawrence Blonde
AMERICAN JOURNAL OF MEDICINE (2010)
Incretin-Based Therapies: Review of Current Clinical Trial Data
Anne Peters
AMERICAN JOURNAL OF MEDICINE (2010)
Overview of Newer Agents: Where Treatment Is Going
Ralph A. DeFronzo
AMERICAN JOURNAL OF MEDICINE (2010)
Diabetes Medications Related to an Increased Risk of Falls and Fall-Related Morbidity in the Elderly
Helen D. Berlie et al.
ANNALS OF PHARMACOTHERAPY (2010)
Rosiglitazone Revisited An Updated Meta-analysis of Risk for Myocardial Infarction and Cardiovascular Mortality
Steven E. Nissen et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Counterpoint: Intensive Glucose Control and Mortality in ACCORD-Still Looking for Clues
Matthew C. Riddle
DIABETES CARE (2010)
Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes
J. Michael Gaziano et al.
DIABETES CARE (2010)
Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes
T. Vilsboll et al.
DIABETES OBESITY & METABOLISM (2010)
Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence
Vivian A. Fonseca et al.
DIABETES OBESITY & METABOLISM (2010)
The combinatorics of medications precludes evidence-based algorithms for therapy
D. Rodbard
DIABETOLOGIA (2010)
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis
G. Schernthaner et al.
DIABETOLOGIA (2010)
Consensus guidelines, algorithms and care of the individual patient with type 2 diabetes
J. J. Nolan
DIABETOLOGIA (2010)
The case for hypoglycaemia as a proarrhythmic event: basic and clinical evidence
C. Nordin
DIABETOLOGIA (2010)
Individualizing Therapies in Type 2 Diabetes Mellitus Based on Patient Characteristics: What We Know and What We Need to Know
Robert J. Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Incorporating Incretin-Based Therapies Into Clinical Practice: Differences Between Glucagon-Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors
Jaime A. Davidson
MAYO CLINIC PROCEEDINGS (2010)
Translating Comparative Effectiveness Into Practice The Case of Diabetes Medications
Nilay D. Shah et al.
MEDICAL CARE (2010)
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study
Denise E. Bonds et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Unraveling the Science of Incretin Biology
Michael A. Nauck
AMERICAN JOURNAL OF MEDICINE (2009)
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Henry Buchwald et al.
AMERICAN JOURNAL OF MEDICINE (2009)
Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes A Cohort Study
Sheldon Greenfield et al.
ANNALS OF INTERNAL MEDICINE (2009)
The Diabetes Mellitus Medication Choice Decision Aid A Randomized Trial
Rebecca J. Mullan et al.
ARCHIVES OF INTERNAL MEDICINE (2009)
Antidiabetic Medication Use and Prevalence of Chronic Kidney Disease Among Patients With Type 2 Diabetes Mellitus in the United States
Carol E. Koro et al.
CLINICAL THERAPEUTICS (2009)
GLP-1 agonist-based therapies: An emerging new class of antidiabetic drug with potential cardioprotective effects
Melanie Sulistio et al.
CURRENT ATHEROSCLEROSIS REPORTS (2009)
Thiazolidinediones and heart failure
Parminder S. Chaggar et al.
DIABETES & VASCULAR DISEASE RESEARCH (2009)
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler et al.
DIABETES CARE (2009)
Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Bernard Zinman et al.
DIABETES CARE (2009)
The importance of titrating starting insulin regimens in patients with type 2 diabetes
A. J. Garber
DIABETES OBESITY & METABOLISM (2009)
Current treatment of non-alcoholic fatty liver disease
Mohamed H. Ahmed et al.
DIABETES OBESITY & METABOLISM (2009)
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
D. M. Nathan et al.
DIABETOLOGIA (2009)
Intensive glucose control and macrovascular outcomes in type 2 diabetes
F. M. Turnbull et al.
DIABETOLOGIA (2009)
STATEMENT BY AN AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CONSENSUS PANEL ON TYPE 2 DIABETES MELLITUS: AN ALGORITHM FOR GLYCEMIC CONTROL
Helena W. Rodbard et al.
ENDOCRINE PRACTICE (2009)
Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control
S. Akalin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2009)
Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
New drugs for the treatment of diabetes - Part II: Incretin-based therapy and beyond
Silvio E. Inzucchi et al.
CIRCULATION (2008)
Four decades of uncertainty: landmark trials in glycaemic control and cardiovascular outcome in type 2 diabetes
David R. Matthews et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Adjust to target in type 2 diabetes - Comparison of a simple algorithm with carbohydrate counting for adjustment of mealtime insulin glulisine
Richard M. Bergenstal et al.
DIABETES CARE (2008)
Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures
Russell E. Glasgow et al.
DIABETES CARE (2008)
Options for the intensification of insulin therapy when basal insulin is not enough in type 2 diabetes mellitus
D. Raccah
DIABETES OBESITY & METABOLISM (2008)
Monogenic diabetes: implications for therapy of rare types of disease
Maciej T. Malecki et al.
DIABETES OBESITY & METABOLISM (2008)
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes
J. Rosenstock et al.
DIABETOLOGIA (2008)
N of 1 trials in diabetes: making individual therapeutic decisions
A. Tsapas et al.
DIABETOLOGIA (2008)
Primary care physicians and insulin initiation: multiple barriers, lack of knowledge or both?
S. Jabbour
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Patient-important outcomes in registered diabetes trials
Gunjan Y. Gandhi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of intensive glucose lowering in type 2 diabetes
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
10-year follow-up of intensive glucose control in type 2 diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Guidelines - Management of type 2 diabetes: updated NICE guidance
Philip Home et al.
BRITISH MEDICAL JOURNAL (2008)
The relationship between glycemic control and falls in older adults
Joan M. Nelson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials
Rodrigo M. Lago et al.
LANCET (2007)
Systematic review: Comparative effectiveness and safety of oral medications for type 2 diabetes Mellitus
Shari Bolen et al.
ANNALS OF INTERNAL MEDICINE (2007)
Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?
A. A. Tahrani et al.
BRITISH MEDICAL JOURNAL (2007)
Diabetes mellitus and heart failure: Epidemiology, mechanisms, and pharmacotherapy
Frederick A. Masoudi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Prandial premixed insulin analogue regimens versus basal insulin analogue regimens in the management of type 2 diabetes: An evidence-based comparison
Liza L. Ilag et al.
CLINICAL THERAPEUTICS (2007)
Pramlintide acetate injection for the treatment of type 1 and type 2 diabetes mellitus
Devada Singh-Franco et al.
CLINICAL THERAPEUTICS (2007)
Initiate insulin by aggressive titration and education (INITIATE) - A randomized study to compare initiation of insulin combination therapy in type 2 diabetic patients individually and in groups
Hannele Yki-Jarvinen et al.
DIABETES CARE (2007)
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Steven E. Kahn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
A self-regulation program for maintenance of weight loss
Rena R. Wing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Incretin mimetics as a novel therapeutic option for hepatic steatosis
Maarten E. Tushuizen et al.
LIVER INTERNATIONAL (2006)
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study
Gillian L. Booth et al.
LANCET (2006)
A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes
Kjeld Hermansen et al.
DIABETES CARE (2006)
Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-Month results of a randomized trial
PJ Elmer et al.
ANNALS OF INTERNAL MEDICINE (2006)
Triple therapy in type 2 diabetes - Insulin glargine or rosiglitazone added to combmiation therapy of sulfonylurea plus metformin in insulin-naive patients
J Rosenstock et al.
DIABETES CARE (2006)
Contraindications can damage your health - is metformin a case in point?
A Holstein et al.
DIABETOLOGIA (2005)
Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus
SM Strowig et al.
DIABETES OBESITY & METABOLISM (2005)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: Results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study
VL Roberts et al.
CLINICAL THERAPEUTICS (2005)
Two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin
J Gerich et al.
DIABETES CARE (2005)
Improvement of glycemic control in subjects with poorly controlled type 2 diabetes - Comparison of two treatment algorithms using insulin glargine
M Davies et al.
DIABETES CARE (2005)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
DM Kendall et al.
DIABETES CARE (2005)
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)
TME Davis et al.
DIABETOLOGIA (2005)
Oral antidiabetic agents - Current role in type 2 diabetes mellitus
AJ Krentz et al.
DRUGS (2005)
Insulin secretagogues, sulfonylurea receptors and K-ATP channels
J Bryan et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: A new analysis
E Ferrannini et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Weight management through lifestyle modification for the prevention and management of type 2 diabetes: Rationale and strategies
S Klein et al.
DIABETES CARE (2004)
Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia
NF Gordon et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Importance of weight management in Type 2 diabetes: Review with meta-analysis of clinical studies
JW Anderson et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2003)
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance - The STOP-NIDDM Ttrial
JL Chiasson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Treatment of patients over 64 years of age with type 2 diabetes - Experience from nateglinide pooled database retrospective analysis
S Del Prato et al.
DIABETES CARE (2003)
Sulfonylureas and cardiovascular effects: from experimental data to clinical use. Available data in humans and clinical applications
JP Riveline et al.
DIABETES & METABOLISM (2003)
The metabolic syndrome - Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
YW Park et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes
PE Cryer
DIABETOLOGIA (2002)
Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus -: A meta-analysis of controlled clinical trials
NG Boulé et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Users' Guides to The Medical Literature - XXV. Evidence-based medicine: Principles for applying the Users' Guides to patient care
GH Guyatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Share Paper
